Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
申请人:Palani Anandan
公开号:US20070173495A1
公开(公告)日:2007-07-26
A compound having the general structure of Formula (I):
or a pharmaceutically acceptable salt, solvate, ester, or tautomer thereof, are useful in treating diseases, disorders, or conditions such as metabolic syndrome and dyslipidemia.